Covidence alternative
Compare Covidence and AIPRA on pricing model, free-tier limits, workflow coverage, and published validation. Competitor figures are sourced from vendor pages as of September 2026.
Covidence is a leading systematic review management platform, often recommended for Cochrane-style workflows. Many researchers search for a Covidence alternative after hitting list pricing, discovering their institution lacks a license, or needing a free tier that can host a real review.
| Dimension | Covidence | AIPRA |
|---|---|---|
| Free / trial | 1 trial review, capped at 500 records (covidence.org/pricing, as of Sep 2026) | Free plan: unlimited projects & collaborators; core workflow |
| Individual paid | $339/year for a single review; $907/year for up to 3 reviews (same source) | Premium $49 plan for premium AI across workflow (aipra.co/pricing) |
| Student discount | FAQ states no additional student discount (LMIC concessions noted) | Free tier available without student application |
| Workflow focus | Import/dedup, dual screening, extraction forms, RoB, PRISMA export; RevMan path | Question → search → screen → extract → synthesis → writing with AI assist |
| Validation / disclosure | Widely used; Cochrane-aligned positioning | Published non-inferiority study + HYMR comparison; AI disclosure boilerplate |
Sources: covidence.org/pricing (as of September 2026); aipra.co/pricing. Verify current prices before purchasing.
When Covidence is still the better fit
- Your institution already provides Covidence site access.
- Your Cochrane review group expects Covidence → RevMan Web.
- You need built-in RoB 2 / ROBINS-I form workflows as the primary product focus.
When AIPRA is a strong alternative
- You need a free tier that is not capped at 500 records.
- You want AI assistance across question framing through drafting—not screening alone.
- You need citable validation and AI disclosure text for manuscripts.
FAQ
- Is there a free Covidence alternative for systematic reviews?
- AIPRA offers a free plan with unlimited projects and collaborators and core workflow tools. Covidence’s public pricing (as of September 2026) lists a trial capped at one review and 500 records, with paid single-review and package plans—not an unlimited free tier.
- Does AIPRA replace Covidence for Cochrane reviews?
- Covidence is widely recommended for Cochrane-aligned review management and RevMan export. AIPRA targets end-to-end AI-assisted workflows with published validation and transparent AI disclosure support. Choose based on institutional requirements, Cochrane group expectations, and whether you need RevMan-native export.
Also see Rayyan alternative and the HYMR narrative comparison.